These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19196721)

  • 41. Usefulness of natriuretic peptide testing for long-term risk assessment following acute ischemic stroke.
    Jensen JK; Atar D; Kristensen SR; Mickley H; Januzzi JL
    Am J Cardiol; 2009 Jul; 104(2):287-91. PubMed ID: 19576362
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Serial bedside B-type natriuretic peptide strongly predicts prognosis in acute coronary syndrome independent of echocardiographic abnormalities.
    Ang DS; Kong CF; Kao MP; Struthers AD
    Am Heart J; 2009 Jul; 158(1):133-40. PubMed ID: 19540403
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increased soluble CD95 (sFas/CD95) serum level correlates with poor prognosis in melanoma patients.
    Ugurel S; Rappl G; Tilgen W; Reinhold U
    Clin Cancer Res; 2001 May; 7(5):1282-6. PubMed ID: 11350895
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role for precursor Pro-B type natriuretic peptide in assessing response to therapy and prognosis in patients with decompensated heart failure treated with nesiritide.
    Miller WL; Burnett JC; Hartman KA; Hodge DO; Giuliani I; Minard F; Larue C; Jaffe AS
    Clin Chim Acta; 2009 Aug; 406(1-2):119-23. PubMed ID: 19523938
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diagnostic and prognostic value of uric acid in patients with acute dyspnea.
    Reichlin T; Potocki M; Breidthardt T; Noveanu M; Hartwiger S; Burri E; Klima T; Stelzig C; Laule K; Mebazaa A; Christ M; Mueller C
    Am J Med; 2009 Nov; 122(11):1054.e7-1054.e14. PubMed ID: 19854335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early assessment of outcome in cardiogenic shock: relevance of plasma N-terminal pro-B-type natriuretic peptide and interleukin-6 levels.
    Jarai R; Fellner B; Haoula D; Jordanova N; Heinz G; Karth GD; Huber K; Geppert A
    Crit Care Med; 2009 Jun; 37(6):1837-44. PubMed ID: 19384228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Apoptosis markers soluble Fas (sFas), Fas Ligand (FasL) and sFas/FasL ratio in patients with bacteremia: a prospective cohort study.
    Huttunen R; Syrjänen J; Vuento R; Laine J; Hurme M; Aittoniemi J
    J Infect; 2012 Mar; 64(3):276-81. PubMed ID: 22207003
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Does clinician's knowledge of B-type natriuretic peptide levels translate to improvement of quality of life and less hospitalization days in patients with heart failure?
    Ancheta IB; Evans M; Miller AB; Chiong JR; Battie C
    Prog Cardiovasc Nurs; 2009 Mar; 24(1):12-8. PubMed ID: 19261138
    [TBL] [Abstract][Full Text] [Related]  

  • 50. B-type natriuretic peptide levels predict event-free survival in patients with implantable cardioverter defibrillators.
    Christ M; Sharkova J; Bayrakcioglu S; Herzum I; Mueller C; Grimm W
    Eur J Heart Fail; 2007 Mar; 9(3):272-9. PubMed ID: 17027335
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and prognostic value of advanced glycation end-products in chronic heart failure.
    Hartog JW; Voors AA; Schalkwijk CG; Scheijen J; Smilde TD; Damman K; Bakker SJ; Smit AJ; van Veldhuisen DJ
    Eur Heart J; 2007 Dec; 28(23):2879-85. PubMed ID: 17986469
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum cortisol as a useful predictor of cardiac events in patients with chronic heart failure: the impact of oxidative stress.
    Yamaji M; Tsutamoto T; Kawahara C; Nishiyama K; Yamamoto T; Fujii M; Horie M
    Circ Heart Fail; 2009 Nov; 2(6):608-15. PubMed ID: 19919986
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
    Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
    Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lowered B-type natriuretic peptide in response to levosimendan or dobutamine treatment is associated with improved survival in patients with severe acutely decompensated heart failure.
    Cohen-Solal A; Logeart D; Huang B; Cai D; Nieminen MS; Mebazaa A
    J Am Coll Cardiol; 2009 Jun; 53(25):2343-8. PubMed ID: 19539144
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state.
    Förhécz Z; Gombos T; Borgulya G; Pozsonyi Z; Prohászka Z; Jánoskuti L
    Am Heart J; 2009 Oct; 158(4):659-66. PubMed ID: 19781428
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Decrease of plasma N-terminal pro beta-type natriuretic peptide as a predictor of clinical improvement after cardiac resynchronization therapy for heart failure.
    Ding LG; Hua W; Zhang S; Chu JM; Chen KP; Wang Y; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Mar; 122(6):617-21. PubMed ID: 19323922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating osteoprotegerin levels and long-term prognosis in patients with acute coronary syndromes.
    Omland T; Ueland T; Jansson AM; Persson A; Karlsson T; Smith C; Herlitz J; Aukrust P; Hartford M; Caidahl K
    J Am Coll Cardiol; 2008 Feb; 51(6):627-33. PubMed ID: 18261681
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma aldosterone levels during hospitalization are predictive of survival post-myocardial infarction.
    Palmer BR; Pilbrow AP; Frampton CM; Yandle TG; Skelton L; Nicholls MG; Richards AM
    Eur Heart J; 2008 Oct; 29(20):2489-96. PubMed ID: 18757359
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence and prognostic significance of elevated gamma-glutamyltransferase in chronic heart failure.
    Poelzl G; Eberl C; Achrainer H; Doerler J; Pachinger O; Frick M; Ulmer H
    Circ Heart Fail; 2009 Jul; 2(4):294-302. PubMed ID: 19808352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.